Alfred Sandrock Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alfred Sandrock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alfred Sandrock. Alfred Sandrock is a EVP CMO Neuro & Neurodegenerat in BIOGEN INC. ($IDPH) and a EVP, Chief Medical Officer in BIOGEN INC. ($IDPH) and a EVP, Research & Development in BIOGEN INC. ($IDPH) and a Grp SVP, Chief Medical Officer in BIOGEN INC. ($IDPH) and a Head of Research & Development in BIOGEN INC. ($IDPH) and a Director in NEUROCRINE BIOSCIENCES INC ($NBIX).
Address: BIOGEN IDEC INC. 133 BOSTON POST RD. WESTON 02493 MA
Companies in which Alfred Sandrock is an Insider
BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Alfred Sandrock: Head of Research & Development, EVP, Research & Development, EVP, Chief Medical Officer, EVP CMO Neuro & Neurodegenerat, Grp SVP, Chief Medical Officer
Holdings: 10,169 shares
Latest Transaction: Jun 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROCRINE BIOSCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Alfred Sandrock: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 23 2019
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Alfred Sandrock
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | Head of Research & ... | Sell | S | 440.00 | 7,672 | 3,375,680 | 10,169 | 17.8 K to 10.2 K (-43.00 %) |
| Jun 09 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | Head of Research & ... | Sell | S | 440.00 | 7,672 | 3,375,680 | 10,169 | 17.8 K to 10.2 K (-43.00 %) |
| Feb 22 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | A | 0.00 | 14,500 | 0 | 14,500 | |
| Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 2,310 | 0 | 8,042 | |
| Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,708 | 0 | 10,352 | |
| Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | J | 0.00 | 1,996 | 0 | 3,446 | |
| Feb 17 2021 | IDPH | BIOGEN INC. | Sandrock Alfred | EVP, Research & Dev ... | Option Exercise | M | 0.00 | 1,446 | 0 | 5,442 |